Ceridian HCM (CDAY) Financials

$54.15 -0.85 (-1.55%)

As of 04/17/2025

Annual Income Statements for Ceridian HCM

This table shows Ceridian HCM's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	-93	3.30	-61	79	-4.00	-75	-73	55	18
Consolidated Net Income / (Loss)	-93	2.00	-61	79	-4.00	-75	-73	55	18
Net Income / (Loss) Continuing Operations	-105	8.00	-35	79	-4.00	-75	-73	55	18
Total Pre-Tax Income	-99	-41	-27	34	-20	-90	-63	96	38
Total Operating Income	-11	55	56	72	7.80	-36	-26	133	104
Total Gross Profit	227	270	315	368	341	382	473	647	812
Total Revenue	623	676	741	824	843	1,024	1,246	1,514	1,760
Operating Revenue	623	676	741	824	843	1,024	1,246	1,514	1,760
Total Cost of Revenue	396	407	426	456	501	642	773	867	948
Operating Cost of Revenue	396	407	426	456	501	642	773	867	948
Total Operating Expenses	238	214	259	296	334	418	499	513	708
Selling, General & Admin Expense	225	214	259	296	334	199	248	263	366
Marketing Expense	-	-	-	-	-	219	252	250	342
Total Other Income / (Expense), net	-87	-96	-83	-38	-28	-55	-37	-37	-67
Interest Expense	87	87	83	32	25	36	29	36	41
Other Income / (Expense), net	-	-8.80	0.20	-5.60	-2.70	-19	-8.50	-1.00	-26
Income Tax Expense	6.70	-49	8.40	-44	-16	-15	11	41	20
Basic Earnings per Share	($1.65)	($0.26)	($0.60)	$0.55	($0.03)	($0.50)	($0.48)	$0.35	$0.11
Weighted Average Basic Shares Outstanding	64.99M	65.20M	114.05M	142.05M	146.77M	150.40M	152.90M	155.30M	157.80M
Diluted Earnings per Share	($1.65)	($0.26)	($0.60)	$0.53	($0.03)	($0.50)	($0.48)	$0.35	$0.11
Weighted Average Diluted Shares Outstanding	64.99M	65.20M	114.05M	148.76M	146.77M	150.40M	152.90M	158.50M	160.40M
Weighted Average Basic & Diluted Shares Outstanding	64.99M	65.20M	101M	143.10M	148.80M	152.05M	154.11M	156.60M	158.92M

This table shows Ceridian HCM's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Income / (Loss) Attributable to Common Shareholders	-21	-5.20	9.90	3.10	-3.80	46	7.10	-1.80	2.00	11
Consolidated Net Income / (Loss)	-21	-5.20	9.90	3.10	-3.80	46	7.10	-1.80	2.00	11
Net Income / (Loss) Continuing Operations	-21	-5.20	9.90	3.10	-3.80	46	7.10	-1.80	2.00	11
Total Pre-Tax Income	-17	-2.50	28	20	13	36	18	0.00	18	0.90
Total Operating Income	-3.70	3.30	38	29	27	39	41	14	21	29
Total Gross Profit	119	135	160	156	161	170	205	187	201	219
Total Revenue	316	336	371	366	378	400	432	423	440	465
Operating Revenue	316	336	371	366	378	400	432	423	440	465
Total Cost of Revenue	197	201	210	210	217	230	226	237	239	247
Operating Cost of Revenue	197	201	210	210	217	230	226	237	239	247
Total Operating Expenses	123	132	122	127	134	131	165	173	181	190
Selling, General & Admin Expense	123	-120	68	65	72	58	86	90	94	97
Marketing Expense	-	-	54	62	62	73	79	83	86	94
Total Other Income / (Expense), net	-13	-5.80	-10	-9.80	-14	-3.30	-22	-14	-2.50	-28
Interest Expense	7.40	8.70	9.20	9.10	8.90	8.90	13	11	8.80	7.40
Other Income / (Expense), net	-5.90	2.90	-0.80	-0.70	-5.10	5.60	-9.00	-3.00	6.30	-20
Income Tax Expense	4.00	2.70	19	17	16	-10	11	1.80	16	-9.90
Basic Earnings per Share	($0.14)	($0.03)	$0.06	$0.02	($0.02)	$0.29	$0.05	($0.01)	$0.01	$0.06
Weighted Average Basic Shares Outstanding	153.18M	152.90M	154.20M	155.10M	155.70M	155.30M	156.90M	157.90M	158.10M	157.80M
Diluted Earnings per Share	($0.14)	($0.03)	$0.06	$0.02	($0.02)	$0.29	$0.04	($0.01)	$0.01	$0.07
Weighted Average Diluted Shares Outstanding	153.18M	152.90M	157.70M	157.60M	155.70M	158.50M	159.90M	157.90M	159.70M	160.40M
Weighted Average Basic & Diluted Shares Outstanding	153.59M	154.11M	155.03M	155.61M	156.13M	156.60M	157.90M	158.10M	157.70M	158.92M

This table details how cash moves in and out of Ceridian HCM's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Change in Cash & Equivalents	58	338	-1,293	552	570	-192	508	270	-168
Net Cash From Operating Activities	-76	-40	9.50	51	-30	49	133	220	281
Net Cash From Continuing Operating Activities	-73	-29	11	51	-30	49	133	220	281
Net Income / (Loss) Continuing Operations	-105	8.00	-35	79	-4.00	-75	-73	55	18
Consolidated Net Income / (Loss)	-93	2.00	-61	79	-4.00	-75	-73	55	18
Depreciation Expense	53	54	57	57	52	78	89	133	210
Amortization Expense	3.50	3.70	2.10	1.20	1.20	17	4.60	4.40	4.20
Non-Cash Adjustments To Reconcile Net Income	33	17	52	45	89	109	152	144	159
Changes in Operating Assets and Liabilities, net	-58	-112	-65	-131	-168	-79	-39	-116	-110
Net Cash From Investing Activities	763	-40	-51	-119	39	-711	-343	-203	-472
Net Cash From Continuing Investing Activities	724	-39	-51	-119	39	-711	-343	-203	-472
Purchase of Property, Plant & Equipment	-33	-18	-40	-55	-60	-64	-95	-114	-110
Acquisitions	-	-0.50	0.00	-30	-58	-410	0.00	0.00	-173
Purchase of Investments	-700	-599	-855	-408	-212	-764	-653	-535	-557
Divestitures	102	-	-	0.00	0.00	38	0.00	0.00	0.00
Sale and/or Maturity of Investments	678	610	844	375	369	488	405	448	368
Other Investing Activities, net	678	-33	-	-	-	0.00	0.00	-1.00	0.00
Net Cash From Financing Activities	-631	407	-1,252	610	565	492	765	242	60
Net Cash From Continuing Financing Activities	-593	407	-1,252	610	565	492	765	242	60
Repayment of Debt	-12	-26	-1,157	-7.20	-305	-304	-8.40	-7.90	-660
Repurchase of Common Equity	-	-1.80	-	-	-	-	0.00	0.00	-36
Issuance of Debt	-	0.00	680	0.00	295	857	0.00	0.00	650
Issuance of Common Equity	75	78	641	87	92	95	38	49	57
Other Financing Activities, net	-656	356	-1,415	530	484	-156	735	201	49
Other Net Changes in Cash	1.30	-	-	-	-	-21	-47	-	-36
Cash Interest Paid	85	90	75	37	27	19	30	52	45
Cash Income Taxes Paid	15	21	21	36	4.20	33	18	43	56

This table details how cash moves in and out of Ceridian HCM's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Change in Cash & Equivalents	-1,293	27	2,190	-1,900	175	-195	1,478	-1,767	-1,055	1,176
Net Cash From Operating Activities	52	42	11	82	37	90	9.10	99	92	81
Net Cash From Continuing Operating Activities	52	42	11	82	37	90	9.10	99	92	81
Net Income / (Loss) Continuing Operations	-21	-5.20	9.90	3.10	-3.80	46	7.10	-1.80	2.00	11
Consolidated Net Income / (Loss)	-21	-5.20	9.90	3.10	-3.80	46	7.10	-1.80	2.00	11
Depreciation Expense	22	25	22	23	39	48	49	51	52	58
Amortization Expense	1.00	1.60	1.10	1.10	1.10	1.10	1.10	1.00	1.10	1.00
Non-Cash Adjustments To Reconcile Net Income	42	32	44	42	38	21	46	46	21	46
Changes in Operating Assets and Liabilities, net	8.10	-12	-65	13	-38	-26	-94	3.10	16	-35
Net Cash From Investing Activities	-43	-48	-1.40	16	-30	-188	-291	-93	-75	-14
Net Cash From Continuing Investing Activities	-43	-48	-1.40	16	-30	-188	-291	-93	-75	-14
Purchase of Property, Plant & Equipment	-23	-30	-28	-28	-32	-26	-28	-27	-28	-27
Purchase of Investments	-84	-119	-73	-29	-150	-283	-140	-187	-166	-64
Sale and/or Maturity of Investments	64	101	101	74	152	121	51	120	120	77
Net Cash From Financing Activities	-1,269	41	2,187	-2,068	226	-103	1,773	-1,765	-1,075	1,127
Net Cash From Continuing Financing Activities	-1,269	41	2,187	-2,068	226	-103	1,773	-1,765	-1,075	1,127
Repayment of Debt	-2.10	-2.10	-2.10	-2.00	-1.90	-1.90	-656	-0.20	-1.80	-1.80
Repurchase of Common Equity	-	-	-	-	-	-	-	-	-	-7.30
Issuance of Common Equity	9.30	16	15	8.40	17	8.70	15	1.50	5.20	35
Other Financing Activities, net	-1,277	28	2,174	-2,074	211	-110	1,764	-1,767	-1,050	1,102
Other Net Changes in Cash	-33	-9.00	-6.80	70	-	-	-	-	-	-18

This table presents Ceridian HCM's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	6,730	5,248	6,086	6,701	7,166	8,464	9,011	9,117
Total Current Assets	4,458	2,934	3,624	4,123	4,144	5,440	5,955	5,984
Cash & Equivalents	94	218	281	188	368	432	570	580
Restricted Cash	4,100	2,604	3,204	3,759	3,536	4,730	5,029	5,002
Accounts Receivable	67	64	80	101	146	180	229	265
Prepaid Expenses	36	49	58	74	93	98	127	138
Plant, Property, & Equipment, net	102	104	128	136	128	175	210	224
Total Noncurrent Assets	2,170	2,209	2,334	2,442	2,894	2,848	2,846	2,910
Goodwill	1,961	1,927	1,974	2,032	2,324	2,280	2,294	2,337
Intangible Assets	207	188	178	195	333	282	230	189
Other Noncurrent Operating Assets	2.00	94	182	216	238	287	322	384
Total Liabilities & Shareholders' Equity	6,730	5,248	6,086	6,701	7,166	8,464	9,011	9,117
Total Liabilities	5,601	3,632	4,203	4,603	4,939	6,354	6,613	6,571
Total Current Liabilities	4,283	2,770	3,363	3,864	211	5,080	5,335	5,315
Short-Term Debt	-	6.80	11	7.20	8.30	7.80	7.60	7.30
Accounts Payable	44	42	43	39	52	54	67	77
Accrued Expenses	15	24	14	21	25	24	30	32
Customer Deposits	-	-	-	3,698	-	4,845	5,090	5,024
Current Deferred Revenue	14	23	26	24	49	41	40	42
Current Employee Benefit Liabilities	69	55	76	65	77	97	93	127
Total Noncurrent Liabilities	1,318	863	841	750	4,728	1,274	1,285	1,262
Long-Term Debt	1,120	664	666	661	1,124	1,213	1,210	1,209
Capital Lease Obligations	-	0.00	8.80	11	11	-	7.00	5.70
Noncurrent Employee Benefit Liabilities	152	153	117	24	21	18	28	5.90
Other Noncurrent Operating Liabilities	46	46	48	54	3,572	43	40	41
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,129	1,616	1,882	2,098	2,228	2,109	2,398	2,546
Total Preferred & Common Equity	1,091	1,616	1,882	2,098	2,228	2,109	2,398	2,546
Total Common Equity	906	1,616	1,882	2,098	2,228	2,109	2,398	2,546
Common Stock	1,566	2,327	2,451	2,608	2,862	2,967	3,153	3,365
Retained Earnings	-348	-336	-230	-234	-309	-373	-318	-336
Accumulated Other Comprehensive Income / (Loss)	-312	-376	-338	-276	-325	-485	-437	-483

This table presents Ceridian HCM's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Total Assets	8,006	8,464	10,062	8,119	8,943	9,011	10,775	9,046	8,117	9,117
Total Current Assets	5,007	5,440	7,042	5,067	5,915	5,955	7,555	5,837	4,904	5,984
Cash & Equivalents	408	432	429	487	510	570	393	465	494	580
Restricted Cash	4,336	4,730	6,285	4,263	5,049	5,029	6,747	4,970	4,001	5,002
Accounts Receivable	155	180	205	205	236	229	276	261	256	265
Prepaid Expenses	107	98	122	113	119	127	140	140	153	138
Plant, Property, & Equipment, net	145	175	186	198	211	210	215	220	228	224
Total Noncurrent Assets	2,855	2,848	2,834	2,853	2,818	2,846	3,005	2,990	2,985	2,910
Goodwill	2,262	2,280	2,281	2,288	2,271	2,294	2,386	2,383	2,395	2,337
Intangible Assets	298	282	275	268	245	230	287	256	228	189
Other Noncurrent Operating Assets	294	287	278	298	302	322	332	350	362	384
Total Liabilities & Shareholders' Equity	8,006	8,464	10,062	8,119	8,943	9,011	10,775	9,046	8,117	9,117
Total Liabilities	5,955	6,354	7,867	5,879	6,676	6,613	8,342	6,570	5,561	6,571
Total Current Liabilities	4,676	5,080	205	4,604	5,412	5,335	7,049	5,280	4,278	5,315
Short-Term Debt	8.10	7.80	7.70	7.60	7.50	7.60	5.60	7.30	7.30	7.30
Accounts Payable	57	54	61	65	67	67	69	66	73	77
Accrued Expenses	24	24	31	36	42	30	42	42	66	32
Customer Deposits	4,457	4,845	-	4,374	5,166	5,090	6,816	5,032	4,005	5,024
Current Deferred Revenue	43	41	47	44	48	40	46	47	43	42
Current Employee Benefit Liabilities	73	97	58	71	76	93	64	80	78	127
Total Noncurrent Liabilities	1,294	1,274	7,662	1,282	1,272	1,285	1,300	1,296	1,289	1,262
Long-Term Debt	1,214	1,213	1,212	1,212	1,211	1,210	1,212	1,211	1,210	1,209
Capital Lease Obligations	15	-	7.70	7.30	6.90	7.00	6.40	5.90	6.00	5.70
Noncurrent Employee Benefit Liabilities	19	18	16	14	12	28	27	26	25	5.90
Other Noncurrent Operating Liabilities	46	43	6,426	49	42	40	55	53	48	41
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	2,051	2,109	2,194	2,240	2,267	2,398	2,433	2,476	2,556	2,546
Total Preferred & Common Equity	2,051	2,109	2,194	2,240	2,267	2,398	2,433	2,476	2,556	2,546
Total Common Equity	2,051	2,109	2,194	2,240	2,267	2,398	2,433	2,476	2,556	2,546
Common Stock	2,920	2,967	3,022	3,072	3,125	3,153	3,206	3,248	3,293	3,365
Retained Earnings	-367	-373	-363	-360	-363	-318	-311	-313	-341	-336
Accumulated Other Comprehensive Income / (Loss)	-501	-485	-465	-472	-495	-437	-463	-460	-397	-483

This table displays calculated financial ratios and metrics derived from Ceridian HCM's official financial filings.

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024
Growth Metrics	-	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	8.47%	9.54%	11.26%	2.23%	21.57%	21.68%	21.47%	16.27%
EBITDA Growth	0.00%	128.79%	10.47%	8.70%	-53.52%	-31.15%	48.25%	353.63%	8.62%
EBIT Growth	0.00%	516.07%	20.82%	18.47%	-92.35%	-1,166.67%	36.95%	485.13%	-40.80%
NOPAT Growth	0.00%	594.64%	1.26%	322.43%	-96.71%	-555.13%	27.32%	520.70%	-34.04%
Net Income Growth	0.00%	102.16%	-3,155.00%	228.81%	-105.08%	-1,785.00%	2.65%	174.66%	-66.97%
EPS Growth	0.00%	84.24%	-130.77%	188.33%	-105.66%	-1,566.67%	4.00%	172.92%	-68.57%
Operating Cash Flow Growth	0.00%	47.28%	123.87%	432.63%	-159.68%	261.59%	171.72%	65.54%	28.06%
Free Cash Flow Firm Growth	0.00%	0.00%	-170.85%	136.73%	-52.64%	-355.34%	293.26%	-82.72%	-151.49%
Invested Capital Growth	0.00%	0.00%	74.08%	-71.28%	-27.68%	54.43%	-243.19%	-7.93%	8.30%
Revenue Q/Q Growth	0.00%	0.00%	3.73%	3.39%	0.12%	6.15%	4.53%	4.39%	3.87%
EBITDA Q/Q Growth	0.00%	0.00%	-11.20%	-1.42%	-40.23%	308.16%	17.66%	29.64%	-8.26%
EBIT Q/Q Growth	0.00%	0.00%	-19.69%	-1.48%	-88.86%	28.61%	15.52%	40.68%	-31.58%
NOPAT Q/Q Growth	0.00%	0.00%	-19.97%	-13.93%	-82.02%	40.83%	2.64%	1,028.77%	-40.21%
Net Income Q/Q Growth	0.00%	0.00%	-2,445.83%	0.77%	-133.90%	9.38%	5.53%	1,270.00%	-65.78%
EPS Q/Q Growth	0.00%	0.00%	-433.33%	-5.36%	0.00%	0.00%	5.88%	1,066.67%	-66.67%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	39.71%	-3.07%	-141.20%	270.63%	46.20%	28.06%	-3.07%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	163.04%	312.00%	-130.55%	233.07%	-64.18%	91.02%
Invested Capital Q/Q Growth	0.00%	0.00%	61.85%	-167.87%	-517.34%	77.76%	-25.78%	4.36%	-153.33%
Profitability Metrics	-	-	-	-	-	-	-	-	-
Gross Margin	36.41%	39.86%	42.51%	44.68%	40.51%	37.33%	37.97%	42.71%	46.14%
EBITDA Margin	7.30%	15.39%	15.53%	15.17%	6.90%	3.91%	4.76%	17.77%	16.60%
Operating Margin	-1.80%	8.19%	7.57%	8.77%	0.93%	-3.47%	-2.07%	8.79%	5.91%
EBIT Margin	-1.80%	6.89%	7.60%	8.09%	0.61%	-5.31%	-2.75%	8.73%	4.44%
Profit (Net Income) Margin	-14.89%	0.30%	-8.25%	9.55%	-0.47%	-7.36%	-5.89%	3.62%	1.03%
Tax Burden Percent	94.12%	-4.94%	227.14%	229.45%	20.00%	83.50%	116.69%	57.08%	48.14%
Interest Burden Percent	880.36%	-86.91%	-47.78%	51.42%	-392.16%	165.99%	183.38%	72.67%	48.08%
Effective Tax Rate	0.00%	0.00%	0.00%	-129.45%	0.00%	0.00%	0.00%	42.92%	51.86%
Return on Invested Capital (ROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (ROE)	0.00%	0.18%	-4.45%	4.50%	-0.20%	-3.49%	-3.38%	2.43%	0.73%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Return on Assets (OROA)	0.00%	0.69%	0.94%	1.18%	0.08%	-0.78%	-0.44%	1.51%	0.86%
Return on Assets (ROA)	0.00%	0.03%	-1.02%	1.39%	-0.06%	-1.09%	-0.94%	0.63%	0.20%
Return on Common Equity (ROCE)	0.00%	0.14%	-4.09%	4.50%	-0.20%	-3.49%	-3.38%	2.43%	0.73%
Return on Equity Simple (ROE_SIMPLE)	0.00%	0.18%	-3.78%	4.18%	-0.19%	-3.39%	-3.48%	2.29%	0.71%
Net Operating Profit after Tax (NOPAT)	-7.84	39	39	166	5.46	-25	-18	76	50
NOPAT Margin	-1.26%	5.74%	5.30%	20.13%	0.65%	-2.43%	-1.45%	5.02%	2.85%
Net Nonoperating Expense Percent (NNEP)	0.00%	-2.30%	-3.76%	-3.52%	-0.31%	-1.68%	-1.65%	-0.51%	-0.73%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-0.54%	2.10%	1.33%
Cost of Revenue to Revenue	63.59%	60.14%	57.49%	55.32%	59.49%	62.67%	62.03%	57.29%	53.86%
SG&A Expenses to Revenue	36.14%	31.66%	34.94%	35.91%	39.58%	19.46%	19.86%	17.39%	20.80%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	38.21%	31.66%	34.94%	35.91%	39.58%	40.79%	40.04%	33.92%	40.23%
Earnings before Interest and Taxes (EBIT)	-11	47	56	67	5.10	-54	-34	132	78
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	46	104	115	125	58	40	59	269	292
Valuation Ratios	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.51	2.95	5.19	7.51	7.10	4.67	4.37	4.50
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	561.54
Price to Revenue (P/Rev)	0.74	0.68	6.43	11.85	18.69	15.43	7.91	6.92	6.51
Price to Earnings (P/E)	0.00	140.00	0.00	124.10	0.00	0.00	0.00	191.23	632.89
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.71%	0.00%	0.81%	0.00%	0.00%	0.00%	0.52%	0.16%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	3.52	8.45	14.81	12.74	4.74	4.03	4.03
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	22.70	55.74	214.81	326.22	99.70	22.69	24.29
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	46.37	104.46	2,447.17	0.00	0.00	46.21	90.74
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	66.48	42.00	2,285.82	0.00	0.00	80.34	141.61
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	274.79	137.69	0.00	267.39	44.59	27.81	25.24
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	12.72	48.12	0.00	4.62	27.60	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.99	0.41	0.36	0.32	0.51	0.58	0.51	0.48
Long-Term Debt to Equity	0.00	0.99	0.41	0.36	0.32	0.51	0.58	0.51	0.48
Financial Leverage	0.00	-2.83	-1.95	-1.42	-1.52	-1.39	-1.55	-1.84	-1.77
Leverage Ratio	0.00	5.96	4.36	3.24	3.21	3.21	3.60	3.88	3.67
Compound Leverage Factor	0.00	-5.18	-2.09	1.67	-12.60	5.32	6.61	2.82	1.76
Debt to Total Capital	0.00%	49.80%	29.32%	26.71%	24.43%	33.93%	36.67%	33.80%	32.43%
Short-Term Debt to Total Capital	0.00%	0.00%	0.30%	0.42%	0.26%	0.25%	0.23%	0.21%	0.19%
Long-Term Debt to Total Capital	0.00%	49.80%	29.03%	26.29%	24.17%	33.69%	36.43%	33.59%	32.24%
Preferred Equity to Total Capital	0.00%	8.24%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	1.68%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	0.00%	40.28%	70.68%	73.29%	75.57%	66.07%	63.33%	66.20%	67.57%
Debt to EBITDA	0.00	10.76	5.83	5.49	11.67	28.60	20.59	4.55	4.18
Net Debt to EBITDA	0.00	-29.53	-18.70	-22.40	-56.27	-68.98	-66.46	-16.26	-14.92
Long-Term Debt to EBITDA	0.00	10.76	5.77	5.40	11.55	28.39	20.46	4.52	4.16
Debt to NOPAT	0.00	28.88	17.07	4.13	124.23	-46.04	-67.62	16.12	24.39
Net Debt to NOPAT	0.00	-79.27	-54.77	-16.88	-598.77	111.04	218.22	-57.58	-86.99
Long-Term Debt to NOPAT	0.00	28.88	16.90	4.07	122.91	-45.70	-67.19	16.02	24.24
Altman Z-Score	0.00	0.13	0.91	1.56	2.18	2.64	1.05	1.20	1.30
Noncontrolling Interest Sharing Ratio	0.00%	19.77%	8.13%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-
Current Ratio	0.00	1.04	1.06	1.08	1.07	19.67	1.07	1.12	1.13
Quick Ratio	0.00	0.04	0.10	0.11	0.07	2.44	0.12	0.15	0.16
Cash Flow Metrics	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	2,105	-1,491	548	259	-662	1,280	221	-114
Operating Cash Flow to CapEx	-229.48%	-227.43%	23.63%	91.67%	-50.50%	76.61%	140.32%	191.87%	256.48%
Free Cash Flow to Firm to Interest Expense	0.00	24.16	-17.92	16.90	10.33	-18.45	44.75	6.13	-2.81
Operating Cash Flow to Interest Expense	-0.86	-0.46	0.11	1.56	-1.20	1.36	4.64	6.08	6.92
Operating Cash Flow Less CapEx to Interest Expense	-1.24	-0.66	-0.37	-0.14	-3.59	-0.42	1.33	2.91	4.22
Efficiency Ratios	-	-	-	-	-	-	-	-	-
Asset Turnover	0.00	0.10	0.12	0.15	0.13	0.15	0.16	0.17	0.19
Accounts Receivable Turnover	0.00	10.15	11.35	11.42	9.28	8.28	7.64	7.40	7.13
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	6.63	7.18	7.08	6.37	7.74	8.22	7.86	8.11
Accounts Payable Turnover	0.00	9.16	9.91	10.77	12.21	14.17	14.58	14.33	13.19
Days Sales Outstanding (DSO)	0.00	35.95	32.15	31.96	39.32	44.08	47.80	49.30	51.18
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	39.85	36.82	33.91	29.89	25.76	25.03	25.46	27.67
Cash Conversion Cycle (CCC)	0.00	-3.90	-4.66	-1.95	9.42	18.33	22.77	23.84	23.52
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-
Invested Capital	0.00	-2,066	-536	-917	-1,171	-534	-1,832	-1,977	-1,813
Invested Capital Turnover	0.00	-0.65	-0.57	-1.13	-0.81	-1.20	-1.05	-0.79	-0.93
Increase / (Decrease) in Invested Capital	0.00	-2,066	1,530	-382	-254	637	-1,298	-145	164
Enterprise Value (EV)	0.00	-2,389	2,610	6,967	12,481	13,049	5,912	6,104	7,096
Market Capitalization	462	462	4,761	9,767	15,750	15,808	9,853	10,479	11,455
Book Value per Share	$0.00	$13.89	$11.70	$13.08	$14.20	$14.72	$13.73	$15.36	$16.15
Tangible Book Value per Share	$0.00	($19.35)	($3.62)	($1.87)	($0.87)	($2.83)	($2.94)	($0.81)	$0.13
Total Capital	0.00	2,249	2,286	2,568	2,777	3,372	3,331	3,623	3,768
Total Debt	0.00	1,120	670	686	678	1,144	1,221	1,225	1,222
Total Long-Term Debt	0.00	1,120	664	675	671	1,136	1,213	1,217	1,215
Net Debt	0.00	-3,074	-2,151	-2,800	-3,269	-2,759	-3,941	-4,375	-4,359
Capital Expenditures (CapEx)	33	18	40	55	60	64	95	114	110
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	-4,019	-2,650	-3,214	-3,682	38	-4,794	-4,972	-4,905
Debt-free Net Working Capital (DFNWC)	0.00	175	171	272	266	3,942	368	628	676
Net Working Capital (NWC)	0.00	175	165	261	259	3,933	361	620	669
Net Nonoperating Expense (NNE)	85	37	100	87	9.46	51	55	21	32
Net Nonoperating Obligations (NNO)	0.00	-3,195	-2,151	-2,800	-3,269	-2,761	-3,941	-4,375	-4,359
Total Depreciation and Amortization (D&A)	57	58	59	58	53	94	94	137	214
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	-594.31%	-357.77%	-389.98%	-437.00%	3.75%	-384.68%	-328.45%	-278.70%
Debt-free Net Working Capital to Revenue	0.00%	25.91%	23.13%	32.96%	31.56%	384.86%	29.55%	41.48%	38.41%
Net Working Capital to Revenue	0.00%	25.91%	22.21%	31.65%	30.71%	384.05%	28.93%	40.98%	37.99%
Earnings Adjustments	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($1.65)	($0.46)	($0.62)	$0.55	($0.03)	($0.50)	($0.48)	$0.35	$0.11
Adjusted Weighted Average Basic Shares Outstanding	64.99M	65.20M	140.51M	142.05M	146.77M	150.40M	152.94M	155.30M	157.80M
Adjusted Diluted Earnings per Share	($1.65)	($0.46)	($0.62)	$0.53	($0.03)	($0.50)	($0.48)	$0.35	$0.11
Adjusted Weighted Average Diluted Shares Outstanding	64.99M	65.20M	140.51M	148.76M	146.77M	150.40M	152.94M	158.50M	160.40M
Adjusted Basic & Diluted Earnings per Share	($1.65)	($0.46)	($0.62)	$0.55	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	64.99M	65.20M	114.05M	144.71M	148.80M	152.05M	154.11M	156.60M	158.92M
Normalized Net Operating Profit after Tax (NOPAT)	-7.84	39	39	51	5.46	-25	-18	76	73
Normalized NOPAT Margin	-1.26%	5.74%	5.30%	6.14%	0.65%	-2.43%	-1.45%	5.02%	4.14%
Pre Tax Income Margin	-15.82%	-5.99%	-3.63%	4.16%	-2.37%	-8.82%	-5.05%	6.34%	2.14%
Debt Service Ratios	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-0.13	0.54	0.68	2.06	0.20	-1.52	-1.20	3.66	1.93
NOPAT to Interest Expense	-0.09	0.45	0.47	5.12	0.22	-0.69	-0.63	2.10	1.23
EBIT Less CapEx to Interest Expense	-0.50	0.33	0.19	0.35	-2.18	-3.29	-4.50	0.49	-0.77
NOPAT Less CapEx to Interest Expense	-0.47	0.24	-0.01	3.42	-2.16	-2.47	-3.94	-1.06	-1.47
Payout Ratios	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	90.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	199.45%

This table displays calculated financial ratios and metrics derived from Ceridian HCM's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	22.71%	19.14%	26.36%	21.48%	19.61%	18.92%	16.43%	15.69%	16.56%	16.39%
EBITDA Growth	92.75%	37.87%	1,742.42%	415.53%	360.15%	189.81%	34.21%	18.08%	31.21%	-28.01%
EBIT Growth	50.52%	6,300.00%	302.15%	333.33%	322.92%	616.13%	-15.69%	-61.32%	26.64%	-81.31%
NOPAT Growth	76.88%	26.92%	201.18%	202.20%	-211.04%	2,057.53%	17.32%	112.26%	128.22%	586.21%
Net Income Growth	-0.48%	45.26%	136.13%	115.66%	81.90%	976.92%	-28.28%	-158.06%	152.63%	-76.32%
EPS Growth	0.00%	50.00%	133.33%	115.38%	85.71%	1,066.67%	-33.33%	-150.00%	150.00%	-75.86%
Operating Cash Flow Growth	101.94%	41,900.00%	105.45%	146.08%	-29.75%	115.07%	-19.47%	21.42%	150.82%	-9.90%
Free Cash Flow Firm Growth	-143.02%	304.57%	-136.83%	-151.95%	163.73%	-85.00%	119.88%	140.19%	-323.83%	-8.74%
Invested Capital Growth	39.31%	-243.19%	24.21%	47.45%	-41.94%	-7.93%	-5.79%	-35.37%	65.38%	8.30%
Revenue Q/Q Growth	4.78%	6.50%	10.26%	-1.27%	3.17%	5.88%	7.96%	-1.90%	3.95%	5.73%
EBITDA Q/Q Growth	29.13%	143.61%	87.65%	-12.66%	15.25%	53.43%	-13.10%	-23.16%	28.07%	-15.82%
EBIT Q/Q Growth	21.95%	164.58%	506.45%	-23.67%	-25.44%	107.48%	-28.60%	-64.98%	144.14%	-69.37%
NOPAT Q/Q Growth	43.08%	189.19%	479.48%	-65.26%	-273.25%	718.66%	-68.49%	-37.15%	-76.97%	14,944.71%
Net Income Q/Q Growth	-6.06%	75.24%	290.38%	-68.69%	-222.58%	1,300.00%	-84.43%	-125.35%	211.11%	440.00%
EPS Q/Q Growth	-7.69%	78.57%	300.00%	-66.67%	-200.00%	1,550.00%	-86.21%	-125.00%	200.00%	600.00%
Operating Cash Flow Q/Q Growth	56.93%	-19.77%	-72.97%	623.01%	-55.20%	145.63%	-89.88%	990.11%	-7.46%	-11.76%
Free Cash Flow Firm Q/Q Growth	-142.61%	237.47%	-179.89%	-11.03%	152.26%	-67.64%	5.88%	124.44%	-391.09%	113.19%
Invested Capital Q/Q Growth	40.33%	-25.78%	-79.78%	61.05%	-61.18%	4.36%	-76.22%	50.17%	58.78%	-153.33%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	37.71%	40.20%	43.25%	42.61%	42.52%	42.48%	47.60%	44.13%	45.75%	46.99%
EBITDA Margin	4.21%	9.64%	16.41%	14.51%	16.21%	23.49%	18.91%	14.81%	18.25%	14.53%
Operating Margin	-1.17%	0.98%	10.36%	8.04%	7.02%	9.71%	9.43%	3.33%	4.73%	6.13%
EBIT Margin	-3.04%	1.84%	10.15%	7.84%	5.67%	11.11%	7.35%	2.62%	6.16%	1.78%
Profit (Net Income) Margin	-6.65%	-1.55%	2.67%	0.85%	-1.01%	11.41%	1.65%	-0.43%	0.45%	2.32%
Tax Burden Percent	123.53%	208.00%	34.86%	15.82%	-30.40%	128.45%	38.59%	0.00%	10.93%	1,200.00%
Interest Burden Percent	177.08%	-40.32%	75.53%	68.29%	58.41%	79.96%	58.04%	0.00%	67.53%	10.84%
Effective Tax Rate	0.00%	0.00%	65.14%	84.18%	130.40%	-28.45%	61.41%	0.00%	89.07%	-1,100.00%
Return on Invested Capital (ROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (ROE)	-3.64%	-3.38%	-1.67%	-0.61%	0.19%	2.43%	2.25%	2.00%	2.19%	0.73%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Return on Assets (OROA)	-0.43%	0.29%	1.27%	1.27%	0.97%	1.92%	1.11%	0.50%	1.22%	0.35%
Return on Assets (ROA)	-0.93%	-0.25%	0.33%	0.14%	-0.17%	1.98%	0.25%	-0.08%	0.09%	0.45%
Return on Common Equity (ROCE)	-3.64%	-3.38%	-1.67%	-0.61%	0.19%	2.43%	2.25%	2.00%	2.19%	0.73%
Return on Equity Simple (ROE_SIMPLE)	-3.79%	0.00%	-1.65%	-0.59%	0.18%	0.00%	2.14%	1.90%	2.07%	0.00%
Net Operating Profit after Tax (NOPAT)	-2.59	2.31	13	4.65	-8.06	50	16	9.87	2.27	342
NOPAT Margin	-0.82%	0.69%	3.61%	1.27%	-2.13%	12.47%	3.64%	2.33%	0.52%	73.52%
Net Nonoperating Expense Percent (NNEP)	-0.45%	-0.22%	-0.06%	-0.04%	0.11%	-0.10%	-0.15%	-0.30%	-0.01%	-7.58%
Return On Investment Capital (ROIC_SIMPLE)	-	0.07%	-	-	-	1.38%	-	-	-	9.08%
Cost of Revenue to Revenue	62.29%	59.80%	56.75%	57.39%	57.48%	57.52%	52.40%	55.87%	54.25%	53.01%
SG&A Expenses to Revenue	38.88%	-35.61%	18.27%	17.76%	19.13%	14.59%	19.86%	21.17%	21.39%	20.77%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	38.88%	39.21%	32.89%	34.57%	35.50%	32.77%	38.17%	40.80%	41.02%	40.86%
Earnings before Interest and Taxes (EBIT)	-9.60	6.20	38	29	21	44	32	11	27	8.30
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	13	32	61	53	61	94	82	63	80	68
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	4.17	4.67	5.14	4.63	4.66	4.37	4.25	3.16	3.79	4.50
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	561.54
Price to Revenue (P/Rev)	7.17	7.91	8.53	7.48	7.28	6.92	6.56	4.80	5.71	6.51
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	2,639.58	191.23	198.79	166.28	183.06	632.89
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.04%	0.52%	0.50%	0.60%	0.55%	0.16%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	4.23	4.74	4.38	4.94	4.29	4.03	2.81	2.22	3.78	4.03
Enterprise Value to EBITDA (EV/EBITDA)	100.11	99.70	49.64	42.98	30.00	22.69	15.25	12.09	20.13	24.29
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	264.73	109.06	66.29	46.21	35.03	33.33	56.10	90.74
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	262.92	0.00	924.73	80.34	54.00	42.49	76.50	141.61
Enterprise Value to Operating Cash Flow (EV/OCF)	55.63	44.59	41.89	36.70	36.32	27.81	20.34	15.42	22.11	25.24
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	4.62	0.00	0.00	10.08	27.60	16.21	6.72	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.60	0.58	0.56	0.55	0.54	0.51	0.50	0.49	0.48	0.48
Long-Term Debt to Equity	0.60	0.58	0.56	0.54	0.54	0.51	0.50	0.49	0.48	0.48
Financial Leverage	-1.90	-1.55	-2.76	-1.86	-1.82	-1.84	-2.46	-1.64	-1.58	-1.77
Leverage Ratio	3.98	3.60	4.87	3.97	3.93	3.88	4.50	3.64	3.54	3.67
Compound Leverage Factor	7.05	-1.45	3.68	2.71	2.29	3.10	2.61	0.00	2.39	0.40
Debt to Total Capital	37.62%	36.67%	35.88%	35.38%	35.09%	33.80%	33.46%	33.08%	32.37%	32.43%
Short-Term Debt to Total Capital	0.25%	0.23%	0.23%	0.22%	0.21%	0.21%	0.15%	0.20%	0.19%	0.19%
Long-Term Debt to Total Capital	37.37%	36.43%	35.65%	35.16%	34.87%	33.59%	33.31%	32.88%	32.17%	32.24%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	62.38%	63.33%	64.12%	64.62%	64.91%	66.20%	66.54%	66.92%	67.63%	67.57%
Debt to EBITDA	24.55	20.59	10.51	7.69	5.91	4.55	4.22	4.09	3.84	4.18
Net Debt to EBITDA	-69.59	-66.46	-46.97	-22.07	-20.89	-16.26	-20.42	-14.07	-10.27	-14.92
Long-Term Debt to EBITDA	24.38	20.46	10.45	7.64	5.87	4.52	4.20	4.06	3.82	4.16
Debt to NOPAT	-66.69	-67.62	55.68	-39.29	182.04	16.12	14.94	14.37	14.59	24.39
Net Debt to NOPAT	189.08	218.22	-248.81	112.84	-643.87	-57.58	-72.27	-49.44	-39.03	-86.99
Long-Term Debt to NOPAT	-66.25	-67.19	55.33	-39.05	180.92	16.02	14.88	14.28	14.51	24.24
Altman Z-Score	0.99	1.07	1.77	1.25	1.13	1.17	0.92	0.93	1.30	1.28
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.07	1.07	34.30	1.10	1.09	1.12	1.07	1.11	1.15	1.13
Quick Ratio	0.12	0.12	3.08	0.15	0.14	0.15	0.09	0.14	0.18	0.16
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-946	1,300	-1,039	-1,153	603	195	207	463	-1,349	178
Operating Cash Flow to CapEx	229.52%	141.22%	39.79%	290.75%	115.09%	344.44%	32.62%	374.34%	323.24%	302.24%
Free Cash Flow to Firm to Interest Expense	-127.81	149.45	-112.90	-126.73	67.72	21.91	15.53	41.75	-153.31	24.05
Operating Cash Flow to Interest Expense	7.04	4.80	1.23	8.98	4.11	10.10	0.68	8.94	10.43	10.95
Operating Cash Flow Less CapEx to Interest Expense	3.97	1.40	-1.86	5.89	0.54	7.17	-1.41	6.55	7.20	7.32
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.14	0.16	0.13	0.16	0.17	0.17	0.15	0.19	0.20	0.19
Accounts Receivable Turnover	8.77	7.64	7.58	7.78	7.40	7.40	6.55	7.00	6.89	7.13
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	8.27	8.22	8.28	8.17	8.15	7.86	7.86	7.80	7.71	8.11
Accounts Payable Turnover	15.14	14.58	14.35	14.07	13.61	14.33	13.55	13.82	13.34	13.19
Days Sales Outstanding (DSO)	41.64	47.80	48.14	46.91	49.30	49.30	55.70	52.12	53.00	51.18
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	24.11	25.03	25.43	25.95	26.82	25.46	26.93	26.41	27.36	27.67
Cash Conversion Cycle (CCC)	17.53	22.77	22.71	20.96	22.48	23.84	28.77	25.72	25.64	23.52
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	-1,456	-1,832	-3,293	-1,282	-2,067	-1,977	-3,484	-1,736	-716	-1,813
Invested Capital Turnover	-0.62	-1.05	-0.35	-0.75	-0.82	-0.79	-0.46	-1.08	-1.22	-0.93
Increase / (Decrease) in Invested Capital	943	-1,298	1,052	1,158	-611	-145	-191	-454	1,351	164
Enterprise Value (EV)	5,045	5,912	5,797	6,860	6,224	6,104	4,421	3,620	6,412	7,096
Market Capitalization	8,553	9,853	11,284	10,382	10,558	10,479	10,337	7,832	9,684	11,455
Book Value per Share	$13.40	$13.73	$14.24	$14.45	$14.57	$15.36	$15.51	$15.68	$16.17	$16.15
Tangible Book Value per Share	($3.33)	($2.94)	($2.35)	($2.04)	($1.60)	($0.81)	($1.53)	($1.04)	($0.42)	$0.13
Total Capital	3,288	3,331	3,422	3,467	3,492	3,623	3,656	3,700	3,779	3,768
Total Debt	1,237	1,221	1,228	1,227	1,225	1,225	1,224	1,224	1,223	1,222
Total Long-Term Debt	1,229	1,213	1,220	1,219	1,218	1,217	1,218	1,217	1,216	1,215
Net Debt	-3,507	-3,941	-5,486	-3,523	-4,334	-4,375	-5,916	-4,212	-3,272	-4,359
Capital Expenditures (CapEx)	23	30	28	28	32	26	28	27	28	27
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-4,405	-4,794	130	-4,279	-5,049	-4,972	-6,628	-4,872	-3,862	-4,905
Debt-free Net Working Capital (DFNWC)	340	368	6,844	471	511	628	512	564	633	676
Net Working Capital (NWC)	332	361	6,836	463	503	620	506	556	626	669
Net Nonoperating Expense (NNE)	18	7.51	3.49	1.55	-4.26	4.24	8.60	12	0.27	331
Net Nonoperating Obligations (NNO)	-3,507	-3,941	-5,487	-3,523	-4,334	-4,375	-5,916	-4,212	-3,272	-4,359
Total Depreciation and Amortization (D&A)	23	26	23	24	40	50	50	52	53	59
Debt-free, Cash-free Net Working Capital to Revenue	-369.48%	-384.68%	9.83%	-308.21%	-348.16%	-328.45%	-420.93%	-298.54%	-227.88%	-278.70%
Debt-free Net Working Capital to Revenue	28.49%	29.55%	517.12%	33.90%	35.21%	41.48%	32.52%	34.53%	37.37%	38.41%
Net Working Capital to Revenue	27.81%	28.93%	516.54%	33.35%	34.69%	40.98%	32.16%	34.09%	36.94%	37.99%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.14)	($0.03)	$0.06	$0.02	($0.02)	$0.29	$0.05	($0.01)	$0.01	$0.06
Adjusted Weighted Average Basic Shares Outstanding	153.18M	152.90M	154.25M	155.12M	155.69M	155.30M	156.90M	157.90M	158.10M	157.80M
Adjusted Diluted Earnings per Share	($0.14)	($0.03)	$0.06	$0.02	($0.02)	$0.29	$0.04	($0.01)	$0.01	$0.07
Adjusted Weighted Average Diluted Shares Outstanding	153.18M	152.90M	157.70M	157.55M	155.69M	158.50M	159.90M	157.90M	159.70M	160.40M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	153.59M	154.11M	155.03M	155.61M	156.13M	156.60M	157.90M	158.10M	157.70M	158.92M
Normalized Net Operating Profit after Tax (NOPAT)	-2.59	2.31	27	21	19	27	28	9.87	15	20
Normalized NOPAT Margin	-0.82%	0.69%	7.25%	5.62%	4.91%	6.80%	6.60%	2.33%	3.31%	4.29%
Pre Tax Income Margin	-5.39%	-0.74%	7.66%	5.36%	3.31%	8.88%	4.26%	0.00%	4.16%	0.19%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-1.30	0.71	4.09	3.15	2.40	4.99	2.38	1.00	3.08	1.12
NOPAT to Interest Expense	-0.35	0.27	1.46	0.51	-0.91	5.60	1.18	0.89	0.26	46.22
EBIT Less CapEx to Interest Expense	-4.36	-2.69	1.00	0.07	-1.17	2.06	0.29	-1.39	-0.15	-2.50
NOPAT Less CapEx to Interest Expense	-3.42	-3.14	-1.63	-2.58	-4.48	2.67	-0.92	-1.50	-2.97	42.59
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	199.45%

Frequently Asked Questions About Ceridian HCM's Financials

When does Ceridian HCM's fiscal year end?

According to the most recent income statement we have on file, Ceridian HCM's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Ceridian HCM's net income changed over the last 8 years?

Ceridian HCM's net income appears to be on a downward trend, with a most recent value of $18.10 million in 2024, falling from -$92.80 million in 2016. The previous period was $54.80 million in 2023.

What is Ceridian HCM's operating income?

Ceridian HCM's total operating income in 2024 was $104.10 million, based on the following breakdown:

Total Gross Profit: $812.10 million
Total Operating Expenses: $708 million

How has Ceridian HCM revenue changed over the last 8 years?

Over the last 8 years, Ceridian HCM's total revenue changed from $623.40 million in 2016 to $1.76 billion in 2024, a change of 182.3%.

How much debt does Ceridian HCM have?

Ceridian HCM's total liabilities were at $6.57 billion at the end of 2024, a 0.6% decrease from 2023, and a 17.3% increase since 2017.

How much cash does Ceridian HCM have?

In the past 7 years, Ceridian HCM's cash and equivalents has ranged from $94.20 million in 2017 to $579.70 million in 2024, and is currently $579.70 million as of their latest financial filing in 2024.

How has Ceridian HCM's book value per share changed over the last 8 years?

Over the last 8 years, Ceridian HCM's book value per share changed from 0.00 in 2016 to 16.15 in 2024, a change of 1,614.7%.

Related Companies

This page (NYSE:CDAY) was last updated on 4/19/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Ceridian HCM (CDAY) Financials

Frequently Asked Questions About Ceridian HCM's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Ceridian HCM (CDAY) Financials

Annual Income Statements for Ceridian HCM

Quarterly Income Statements for Ceridian HCM

Annual Cash Flow Statements for Ceridian HCM

Quarterly Cash Flow Statements for Ceridian HCM

Annual Balance Sheets for Ceridian HCM

Quarterly Balance Sheets for Ceridian HCM

Annual Metrics and Ratios for Ceridian HCM

Quarterly Metrics and Ratios for Ceridian HCM

Frequently Asked Questions About Ceridian HCM's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools